Global Food Allergy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Food Allergy Market Analysis

The global food allergy market is driven by the rising prevalence of food allergies, which has become a significant public health concern worldwide. According to the World Allergy Organization (WAO), approximately 220-250 million people globally suffer from food allergies, with the highest prevalence seen in children under the age of 5. In the United States, studies report that 5-8% of children and 2-3% of adults are affected by food allergies, with peanut and milk allergies being the most common among children. Similarly, in Europe, food allergies impact around 6-8% of children and 3-4% of adults, according to the European Academy of Allergy and Clinical Immunology (EAACI). The increasing number of reported anaphylaxis cases due to severe allergic reactions, especially among children, highlights the growing need for effective diagnosis and treatment solutions in this market. This trend is further exacerbated by environmental factors and changing dietary habits in developing regions.

Food Allergy Market Size

Global food allergy market size was valued at USD 2.84 billion in 2024 and is projected to reach USD 5.94 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Food Allergy Market Trends

“Rising Adoption of Diagnostic Tools”

The adoption of advanced diagnostic techniques is transforming the way food allergies are identified and managed. Molecular allergology and component-resolved diagnostics (CRD) are emerging as precise methods for detecting specific allergenic proteins within foods, allowing for a more detailed understanding of individual sensitivities. Unlike traditional skin prick tests and serum IgE measurements, these advanced tools provide improved accuracy by pinpointing the exact allergenic components responsible for triggering reactions. This reduces the occurrence of false positives, which are common with older diagnostic methods, and minimizes unnecessary dietary restrictions. These innovations are particularly beneficial in cases of complex allergies, such as cross-reactivities between different food groups, enabling healthcare professionals to develop targeted management plans. As awareness of these tools grows, they are increasingly being integrated into clinical practice and research, contributing to more effective and personalized allergy care.

Report Scope and Food Allergy Market Segmentation

Food Allergy Market Definition

A food allergy is an adverse immune system reaction triggered by specific proteins in certain foods. It occurs when the body's immune system mistakenly identifies a harmless food protein as harmful and releases chemicals such as histamine, causing symptoms that range from mild (for instance, hives, itching, and stomach pain) to severe (for instance, anaphylaxis, a life-threatening reaction). Common allergens include peanuts, tree nuts, milk, eggs, wheat, soy, fish, and shellfish. Unlike food intolerances, food allergies involve an immune response and can occur even with small amounts of the allergen.

Food Allergy Market Dynamics

Drivers  

• Rising Prevalence of Food Allergies

The rising prevalence of food allergies globally, especially among children, is a critical factor influencing the growth of the food allergy market. According to studies, food allergies affect approximately 5-8% of children and 2-3% of adults, with the most common triggers being peanuts, tree nuts, milk, eggs, and shellfish. This condition often manifests in early childhood, and in many cases, individuals carry these allergies into adulthood, increasing the long-term need for effective management solutions. Severe reactions, such as anaphylaxis, highlight the importance of timely diagnosis and intervention. The growing awareness about food allergies among parents, caregivers, and healthcare providers has amplified the demand for precise diagnostic tools and emergency treatments such as epinephrine auto-injectors. Additionally, allergen-free food products are gaining popularity to accommodate the dietary needs of affected individuals. The increasing prevalence of food allergies underscores the need for innovative diagnostic and treatment solutions, driving advancements in this rapidly evolving market.  

• Advancements in Diagnostic Technologies   

Advancements in diagnostic technologies are significantly enhancing the precision and reliability of food allergy identification. Techniques such as component-resolved diagnostics (CRD) and molecular allergology provide detailed insights by identifying specific allergenic proteins rather than entire food groups. This level of accuracy enables healthcare providers to differentiate between true allergies and cross-reactivities, reducing the false positives commonly associated with traditional methods such as skin prick tests and serum IgE testing. By minimizing unnecessary dietary restrictions and ensuring targeted treatment plans, these tools are improving patient outcomes. Additionally, the growing adoption of these technologies in clinical settings reflects their effectiveness in managing complex allergy cases, such as those involving multiple allergens or severe reactions. The continuous refinement of these diagnostic methods is further supported by ongoing research and integration into routine healthcare practices. Advanced diagnostic technologies are transforming food allergy management, ensuring greater accuracy in detection and paving the way for personalized patient care.

Opportunities

• Growth in Allergen-Free Food Products

The rising awareness of food allergies is driving an increasing demand for allergen-free and "free-from" food products, offering significant opportunities for food manufacturers. With more consumers becoming conscious of potential allergens such as peanuts, milk, eggs, and gluten, there is a growing preference for foods that are free from these common triggers. This trend is not only impacting individuals with diagnosed food allergies but also families seeking to provide safer food options for children. As a result, manufacturers have the chance to innovate and expand their product offerings to meet this demand, creating allergen-free versions of popular foods across various categories such as snacks, dairy, and baked goods. The availability of these products in both mainstream grocery stores and specialty markets further amplifies the growth potential. As the market for allergen-free food products continues to expand, companies that can effectively cater to this need will likely see increased market share. The demand for allergen-free foods presents a lucrative opportunity for manufacturers to diversify their product lines and tap into the growing consumer base seeking safe, allergen-conscious options.

• Development of Immunotherapies and Vaccines

The development of immunotherapies and vaccines presents a promising opportunity in the food allergy market. Oral immunotherapy (OIT), subcutaneous immunotherapy, and vaccines are being researched to help desensitize individuals to specific allergens, aiming to alter the immune response and reduce the severity of allergic reactions. These treatments are designed to gradually expose the immune system to small amounts of allergens, training it to tolerate them over time. This approach could significantly improve the quality of life for individuals with food allergies, reducing the risk of life-threatening reactions and minimizing the need for emergency interventions. Ongoing research and clinical trials are exploring the potential of these therapies, and breakthrough treatments could revolutionize food allergy management in the future. With these innovations on the horizon, the food allergy market is poised for long-term growth as new therapies become available. The development of immunotherapies and vaccines represents a transformative opportunity to enhance treatment options for food allergy sufferers, driving growth and innovation in the market.

Restraints/Challenges

• High Cost of Treatment and Diagnostics

The high cost of treatment and diagnostics presents a significant restraint on the growth of the global food allergy market. Advanced therapies such as oral immunotherapy (OIT), subcutaneous immunotherapy, and vaccines, as well as specialized diagnostic tools such as component-resolved diagnostics (CRD) and molecular allergology, require extensive research, development, and production, leading to high costs. These treatments and diagnostic procedures are often expensive for patients, particularly in regions where healthcare access is limited or insurance coverage is insufficient. The financial burden of these advanced options can make them inaccessible to a large segment of the population, slowing the adoption of innovative therapies and technologies. Additionally, the high cost of allergen-free food products also contributes to this barrier, especially for low-income families. As a result, the widespread use of these solutions may be limited, slowing the overall growth of the food allergy market. The high cost of treatment and diagnostics is a major restraint on the Global Food Allergy Market, limiting access to advanced solutions and slowing market expansion.

• Lack of Standardized Treatment Protocols

The lack of standardized treatment protocols poses a significant challenge in the global food allergy market. Although therapies such as oral immunotherapy (OIT) and vaccines have shown potential in managing food allergies, there is no universally accepted guideline for their use. The effectiveness and safety of these therapies can vary greatly depending on the individual, allergen type, and the severity of the allergy, making it challenging for healthcare providers to deliver consistent, evidence-based care. This lack of standardization can lead to varying patient outcomes, creating confusion for both healthcare professionals and patients. Furthermore, regional differences in healthcare infrastructure, access to resources, and levels of awareness exacerbate the issue, complicating the implementation of standardized treatment approaches. The absence of clear, globally recognized treatment protocols delays the adoption of innovative therapies, limiting their widespread application and slowing progress in food allergy management. The lack of standardized treatment protocols remains a major challenge, hindering the effective and consistent management of food allergies and impeding global progress in patient care.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Food Allergy Market Scope

The market is segmented on the basis of allergen type, diagnosis, treatment, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Allergen Type

• Peanuts
• Tree Nuts
• Milk
• Eggs
• Wheat
• Soy
• Fish
• Shellfish
• Others

Diagnosis

• Skin Prick Tests (SPT)
• Blood Tests (IgE Tests)
• Oral Food Challenge (OFC)
• Patch Testing, Others

Treatment

• Anti-Histamines
• Epinephrine Auto-Injectors
• Immunotherapy
• Dietary Management, Others

End User

• Hospitals
• Clinics
• Diagnostic Centers
• Homecare

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Food Allergy Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, allergen type, diagnosis, treatment, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to its advanced healthcare infrastructure, which supports early diagnosis and effective management of food allergies. High awareness among the population and substantial investments in research and development for innovative treatments and diagnostic technologies further contribute to the region's leadership, enabling improved patient outcomes and fueling market growth.

Asia-Pacific is expected to be the fastest growing due to the rising prevalence of food allergies, particularly in densely populated countries such as India and China, where changing diets and lifestyles contribute to increased cases. Improved healthcare access and growing awareness of allergy management and treatments in emerging economies are driving demand for advanced diagnostic and therapeutic solutions, fostering robust market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Food Allergy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Food Allergy Market Leaders Operating in the Market Are:

• ALK (Denmark)
• Nestlé Health Science (Switzerland)
• Aimmune Therapeutics, Inc. (U.S.)
• Sanofi S.A. (France)
• Stallergenes Greer Ltd. (U.K.)
• DBV Technologies (France)
• Allergy Therapeutics Plc (U.K.)
• Prota Therapeutics Pty Ltd. (Australia)
• Aravax Pty Ltd. (Australia)
• Johnson & Johnson Services, Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• EpiGuard (Norway)
• Medline Industries, LP (U.S.)
• HAL Allergy B.V. (Netherlands)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Viatris Inc. (U.S.)

Latest Developments in Global Food Allergy Market

• In September 2024, Mitsubishi Gas Chemical Company, Inc. has partnered with Detroit-based health tech firm Alerje, Inc. to enhance allergy care through an emergency medicine and food allergy management platform. This collaboration will help Mitsubishi innovate in the allergy care space, expanding its reach in healthcare technology
• In July 2024, BioVaxys Technology Corp. has signed a binding Letter of Intent with AP Visionaries Inc. to co-develop a proprietary DPX formulation aimed at treating life-threatening food allergies, including those triggered by peanuts, tree nuts, and eggs. This collaboration will help BioVaxys expand its portfolio of immune-educating therapies and advance its innovative allergy treatments
• In February 2024, the FDA has approved Xolair as the first and only treatment for children and adults with one or more food allergies, based on data from the NIH-sponsored Phase III OUtMATCH study. This approval will help the company expand Xolair’s market potential in food allergy treatment and offer a new option for patients
• In January 2024, Inimmune Corporation and Intrommune Therapeutics, Inc. have announced a strategic collaboration to combine Intrommune's peanut oral mucosal immunotherapy (OMIT) with Inimmune's proprietary immunotherapy for rapid allergen desensitization. This partnership will enable both companies to advance their food allergy treatments, accelerating their development of innovative immunotherapies
• In January 2024, Intrommune Therapeutics, has launched a Phase 2 clinical study for INT301, a novel toothpaste aimed at treating peanut allergies. This development will help the company advance its food allergy treatment pipeline and bring innovative solutions to market

SKU-54391